Investor Presentation

Key Financial Highlights Revenue (In Mn) 5 Year CAGR - 14% EBITDA (In Mn) & EBITDA Margin (%) 5 Year CAGR -24% 17.32% 15.79% 3,966 13.92% 14.44% 687 3,065 11.62% 2,428 2,499 2,039 484 338 361 237 FAIRCHEM A FAIRFAX COMPANY PAT (In Mn) & PAT Margin (%) 11.32% 10.72% 5 Year CAGR - 36% 5.00% 91 8.00% 8.60% 215 194 425 347 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 Net Debt to Equity 0.69 0.63 0.47 0.48 86 0.28 Cash Conversion Cycle Days 98 94 Return Ratios 31.44% 30.01% 27.52% 28.20% 19.32% 27.39% 87 25.18% 85 22.21% 20.97% 12.59% FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 ROCE ROE Investor Presentation | www.fairchem.in 26 26

View entire presentation